NCT00217503 2013-06-20Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion LymphomaNational Cancer Institute (NCI)Phase 2 Completed15 enrolled